JP2004115513A5 - - Google Patents

Download PDF

Info

Publication number
JP2004115513A5
JP2004115513A5 JP2003328079A JP2003328079A JP2004115513A5 JP 2004115513 A5 JP2004115513 A5 JP 2004115513A5 JP 2003328079 A JP2003328079 A JP 2003328079A JP 2003328079 A JP2003328079 A JP 2003328079A JP 2004115513 A5 JP2004115513 A5 JP 2004115513A5
Authority
JP
Japan
Prior art keywords
vitamin
tocopherol
palmitate
biotin
vitamins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003328079A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004115513A (ja
Filing date
Publication date
Priority claimed from DE10244282A external-priority patent/DE10244282A1/de
Application filed filed Critical
Publication of JP2004115513A publication Critical patent/JP2004115513A/ja
Publication of JP2004115513A5 publication Critical patent/JP2004115513A5/ja
Withdrawn legal-status Critical Current

Links

JP2003328079A 2002-09-23 2003-09-19 抗酸化剤性質を有する製剤 Withdrawn JP2004115513A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10244282A DE10244282A1 (de) 2002-09-23 2002-09-23 Zubereitung mit antioxidanten Eigenschaften

Publications (2)

Publication Number Publication Date
JP2004115513A JP2004115513A (ja) 2004-04-15
JP2004115513A5 true JP2004115513A5 (enExample) 2006-11-02

Family

ID=31896330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003328079A Withdrawn JP2004115513A (ja) 2002-09-23 2003-09-19 抗酸化剤性質を有する製剤

Country Status (4)

Country Link
US (1) US20040067894A1 (enExample)
EP (1) EP1400579A3 (enExample)
JP (1) JP2004115513A (enExample)
DE (1) DE10244282A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
DE10253042A1 (de) * 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
US20040228811A1 (en) * 2003-05-13 2004-11-18 Kimberly-Clark Worldwide, Inc. Sunscreen wipes having high sunscreen formulation transfer rate
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
EP2236131A3 (en) * 2003-07-01 2011-03-02 President and Fellows of Harvard College Sirt1 modulators for manipulating cell/organism lifespan/stress response
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20050171027A1 (en) 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
JP4668553B2 (ja) * 2004-05-27 2011-04-13 サントリーホールディングス株式会社 リパーゼ阻害活性および／または抗酸化活性を有するエピガロカテキン二量体および三量体
WO2006007411A2 (en) * 2004-06-16 2006-01-19 President And Fellows Of Harvard College Methods and compositions for modulating bax-mediated apoptosis
US20060014705A1 (en) * 2004-06-30 2006-01-19 Howitz Konrad T Compositions and methods for selectively activating human sirtuins
DE102004038728A1 (de) * 2004-08-10 2006-03-02 Merck Patent Gmbh Flavonoid-Komplexe
EP1814894B1 (de) * 2004-11-25 2012-08-08 Merck Patent GmbH Flavonoid-komplexe mit cyclodextrinen
CN101137639B (zh) * 2005-03-11 2012-05-23 霍华德弗洛里生理医学实验研究所 类黄酮化合物及其用途
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
DE102005061657A1 (de) 2005-06-16 2006-12-28 Merck Patent Gmbh Verwendung von substituierten Piperazin- und Morpholinderivaten
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
EP2368442B1 (en) 2005-07-27 2014-12-17 Symrise AG Use of hesperetin for enhancing the sweet taste
DE102005047647A1 (de) 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
JP4994684B2 (ja) * 2006-03-20 2012-08-08 株式会社ノエビア 保湿剤、細胞賦活剤、及び抗酸化剤
WO2008076767A1 (en) * 2006-12-13 2008-06-26 Purdue Research Foundation Chemotherapeutic flavonoids, and syntheses thereof
DE102007013366A1 (de) 2007-03-16 2008-09-18 Merck Patent Gmbh Verwendung von Chroman-4-on-Derivaten
DE102007013368A1 (de) 2007-03-16 2008-09-18 Merck Patent Gmbh Verwendung einer Mischung eines Selbstbräuners mit einem Formaldehydfänger
DE102007035567A1 (de) 2007-07-26 2009-01-29 Basf Se UV-Filter-Kapsel
DE102007041854A1 (de) 2007-09-03 2009-03-05 Merck Patent Gmbh Bifunktionelle DHA-Derivate
CN101434593B (zh) * 2007-11-14 2013-05-29 中国医学科学院药物研究所 黄芩素两种晶型物质、其制法和其药物组合物与用途
DE102007057543A1 (de) 2007-11-29 2009-06-04 Merck Patent Gmbh a-Aminosäurederivate zur Löslichkeitsverbesserung
DE102008031480A1 (de) * 2008-07-03 2010-01-07 Merck Patent Gmbh Salze enthaltend ein Pyrimidincarbonsäure-Derivat
DE102009007997A1 (de) 2009-02-07 2010-08-12 Merck Patent Gmbh N-Acyl-ß-aminopropionsäurederivate als Repellentien
JP5172913B2 (ja) * 2010-09-03 2013-03-27 サントリーホールディングス株式会社 リパーゼ阻害活性および／または抗酸化活性を有するエピガロカテキン二量体および三量体
FR2977490B1 (fr) 2011-07-07 2014-03-21 Oreal Composition photoprotectrice
US20140173972A1 (en) * 2012-12-21 2014-06-26 Shell Oil Company Liquid fuel compositions
KR20180120746A (ko) * 2016-03-11 2018-11-06 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 이카리인 및 이카리틴 유도체
FR3060355B1 (fr) 2016-12-21 2020-01-24 L'oreal Emulsion eau-dans-huile contenant la baicaline, une base xanthique, une vitamine b3 et un sel de cation metallique multivalent
FR3060358B1 (fr) 2016-12-21 2019-05-31 L'oreal Composition comprenant de la baicaline, un ester d'acide gras et un alkylpolyglycoside
FR3060357A1 (fr) * 2016-12-21 2018-06-22 L'oreal Composition comprenant de la baicaline et un filtre organique anti-uvs present sous une forme encapsulee
FR3060997B1 (fr) 2016-12-23 2019-05-31 L'oreal Composition comprenant de la baicaline
CN107158386A (zh) * 2017-05-31 2017-09-15 段新方 预防和治疗脱发的药物
FR3073402B1 (fr) 2017-11-15 2020-05-15 L'oreal Composition comprenant de la baicaline et/ou l’un de ses derives et un polymere acrylique particulier
FR3075050B1 (fr) 2017-12-19 2020-01-03 L'oreal Composition comprenant de la baicaline et un compose antioxydant
CN110483541B (zh) * 2019-09-03 2021-08-24 河南中医药大学 一种异戊烯基化黄酮类化合物及其制备方法和应用
CN112480055B (zh) * 2020-12-11 2022-10-21 肇庆学院 一种橙皮素衍生物及其合成方法与用途
FR3128373A1 (fr) 2021-10-22 2023-04-28 Jr Composition pour son utilisation dans la synthese cutanee d’acide hyaluronique, dans la reponse immuno-cutanee et une amelioration de la peau
CN113956244B (zh) * 2021-12-21 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种用于皮肤复新的肌肽衍生物及其用途
WO2025204097A1 (ja) * 2024-03-27 2025-10-02 シプロ化成株式会社 紫外線吸収剤およびそれを含有した樹脂組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550255A (en) * 1946-04-05 1951-04-24 Swift & Co Preservation of food products
JPS63208506A (ja) * 1987-02-24 1988-08-30 Nonogawa Shoji:Kk 化粧料
GB9726401D0 (en) * 1997-02-20 1998-02-11 Univ Robert Gordon Anti-Microbial product
DE19755504A1 (de) * 1997-12-13 1999-06-17 Beiersdorf Ag Verwendung von Flavonen und Flavonoiden gegen die UV-induzierte Zersetzung von Dibenzoylmethan und dessen Derivaten
EP1029849A1 (de) * 1999-02-19 2000-08-23 Haarmann & Reimer Gmbh Hydroxymandelsäureamide phenolischer Amine
AU6174900A (en) * 1999-07-08 2001-01-30 Patrick T. Prendergast Use of flavones, coumarins and related compounds to treat infections
DE10031457C2 (de) * 2000-06-28 2002-12-12 Jean Krutmann Verwendung von O-beta-Hydroxyethylrutosid oder dessen Aglycon zur systemischen Behandlung und Prophylaxe von UV-induzierten Dermatosen und unerwünschten Langzeitfolgen von UV-Bestrahlungen
DE10056400A1 (de) * 2000-11-14 2002-05-23 Merck Patent Gmbh Galenische Formulierung
EP1351679B1 (en) * 2000-12-21 2010-02-03 The Quigley Corporation Method and composition for the treatment of diabetic neuropathy
US6753325B2 (en) * 2001-11-06 2004-06-22 The Quigley Corporation Composition and method for prevention, reduction and treatment of radiation dermatitis

Similar Documents

Publication Publication Date Title
JP2004115513A5 (enExample)
PL376154A1 (en) Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
IL175252A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
EP1435894A4 (en) CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS AND METHOD
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
IL173807A0 (en) Amphiphilic antioxidant compounds, mitoquinone derivatives and pharmaceutical compositions containing the same
IL206831A0 (en) Glucopyranosyl derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
EP2615087A3 (en) Phenylalanine derivatives
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
AU2003216934A1 (en) Benzoxazinone derivatives, the preparation and use thereof as medicaments
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
ATE323092T1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE247953T1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
ATE337317T1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
AU2003292381A1 (en) Naphthyridine derivatives and their use as fungicides
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same